Efficacy of long-term treatment for > 5-10 years with the LHRH analog leuprorelin acetate in patients with prostate ancer: Results from a noninterventional study

Authors :: Peter Hammerer
Manfred P. Wirth
Source :: Journal of Clinical Oncology. 32:e16077-e16077
Publication Year :: 2014
Publisher :: American Society of Clinical Oncology (ASCO), 2014.
Abstract: e16077 Background: LHRH analogs (LHRHa) are standard of care in the treatment of advanced and metastatic prostate cancer (PCa). The most widely prescribed LHRHa leuprorelin acetate is in clinical u...

Subjects :: Cancer Research
medicine.medical_specialty
Long term treatment
Standard of care
business.industry
Urology
medicine.disease
Prostate cancer
medicine.anatomical_structure
Oncology
Leuprorelin
Prostate
medicine
In patient
Lhrh analog
business
hormones, hormone substitutes, and hormone antagonists
medicine.drug

Full Text Access

Tools